BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

BioCardia (NASDAQ:BCDA) will host a conference call on Wednesday, August 12, 2026 at 4:30 PM EDT to provide a corporate update and report its Q2 2026 financial results.

Rhea-AI Summary

BioCardia (NASDAQ:BCDA) will host a conference call on Wednesday, August 12, 2026 at 4:30 PM EDT to provide a corporate update and report its Q2 2026 financial results. The event will include prepared remarks followed by a question-and-answer session.

Participants can register online to receive dial-in details or join by phone at 1-833-316-0559 (U.S.) or 1-412-317-5730 (international). A live webcast and both webcast and telephonic replays will be available, with webcast replay access through approximately November 12, 2026.

Argus Aug 5 session 8 alerts

+4.37% close to close 1.1x rel. volume Open Argus

Details

News Market Reaction – BCDA

+3.1% Peak Tracked

-7.0% Trough Tracked

$13.32M Market Cap

In the Aug 5 session, BCDA gained 4.37%, reflecting a moderate positive market reaction. Argus tracked a peak move of +3.1% during that session. Argus tracked a trough of -7.0% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Net Buying was recorded across the recent insider dataset, adding platform context to this scheduled...

Analysis

Net Buying was recorded across the recent insider dataset, adding platform context to this scheduled Q2 update. High short positioning remained a risk factor; investors could watch the reported results and corporate update.

Key Figures

Reporting period: Q2 2026 Conference call date: August 12, 2026 Conference call time: 4:30 PM EDT

Reporting period

Q2 2026

Financial results to be reported

Conference call date

August 12, 2026

Scheduled corporate update and results call

Conference call time

4:30 PM EDT

Scheduled start time

Previous Conferences,earnings date Reports

5 past events · Latest: May 11

Same Type 5 events

1. May 11

   Q1 call scheduled

   24h Move

   +0.9%

   Q1 2026 results and corporate update call scheduled for May 15

2. Mar 19

   Annual call scheduled

   24h Move

   +0.0%

   2025 financial results and corporate update call scheduled for March 24

3. Nov 05

   Q3 call scheduled

   24h Move

   -3.0%

   Q3 2025 corporate update and financial results call scheduled for November 12

4. Aug 06

   Q2 call scheduled

   24h Move

   -5.5%

   Q2 2025 corporate update and financial results call scheduled for August 11

5. May 09

   Q1 call scheduled

   24h Move

   -0.3%

   Q1 2025 corporate update and financial results call scheduled for May 14

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SUNNYVALE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BioCardia^®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the second quarter of 2026 by conference call on Wednesday, August 12, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session.

Participants can register for the conference by navigating to: https://dpregister.com/sreg/10211154/104a4f51d2e.

Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730. All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to join the BioCardia call. The conference call will also be available through a live webcast, which can be accessed through the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ufQzaenK.

A webcast replay of the call will be available approximately one hour after the end of the call through approximately November 12, 2026 at the following link: https://services.choruscall.com/ccforms/replay.html. A telephonic replay of the call will also be available and may be accessed by calling 1-855-669-9658 (toll free domestic/Canada), 1-412-317-0088 (international toll) by using access code 3063624.

About BioCardia^®
BioCardia, Inc., headquartered in Sunnyvale, California, is a developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP^® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph^® vascular navigation product platforms, and soon the Heart 3D™ fusion imaging platform. BioCardia selectively partners on biotherapeutic delivery with peers developing important biological therapies. For more information visit www.biocardia.com.

MEDIA CONTACT:
Miranda Peto, Investor Relations
mpeto@biocardia.com
(650) 226-0120

INVESTOR CONTACT:
David McClung, Chief Financial Officer
investors@biocardia.com
(650) 226-0120

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioCardia (NASDAQ:BCDA) reporting its Q2 2026 financial results?

BioCardia will report its Q2 2026 financial results on a conference call on August 12, 2026 at 4:30 PM EDT. According to BioCardia, the call will also include a broader corporate update and Q&A session.

How can investors join the BioCardia (BCDA) Q2 2026 earnings conference call by phone?

Investors can join the BioCardia Q2 2026 call by dialing 1-833-316-0559 in the U.S. or 1-412-317-5730 internationally. According to BioCardia, callers should dial in about 10 minutes early and request the BioCardia call.

How do I register online for the BioCardia (BCDA) Q2 2026 conference call?

Investors can register online for the BioCardia Q2 2026 call at https://dpregister.com/sreg/10211154/104a4f51d2e. According to BioCardia, registered participants will receive their specific dial-in number after completing the online registration process.

Will there be a webcast of the BioCardia (NASDAQ:BCDA) Q2 2026 results call?

Yes, the BioCardia Q2 2026 results call will be available via live webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=ufQzaenK. According to BioCardia, the webcast provides an alternative to telephone access for investors.

How can I listen to the replay of BioCardia’s Q2 2026 earnings call?

A webcast replay will be available about one hour after the call and accessible through around November 12, 2026. According to BioCardia, telephonic replay is also available at 1-855-669-9658 (U.S./Canada) or 1-412-317-0088 using access code 3063624.

What topics will BioCardia (BCDA) cover during the August 12, 2026 conference call?

BioCardia plans to provide a corporate update and report Q2 2026 financial results on the call. According to BioCardia, management will deliver formal remarks followed by a question-and-answer session for participants.